← Back to Search

CLS-R-FUERTE for Oppositional Defiant Disorder

N/A
Waitlist Available
Led By Lauren M Haack, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and post treatment (8 weeks)
Awards & highlights

Study Summary

This trial focuses on training school clinicians to deliver an evidence-based intervention for Attention-Deficit/Hyperactivity Disorder (ADHD) and Oppositional Defiant Disorder (ODD) remotely. It is predicted that the school clinicians will be satisfied with the program and that the youth will show improved ADHD/ODD symptoms.

Eligible Conditions
  • Oppositional Defiant Disorder
  • ODD
  • Attention Deficit Hyperactivity Disorder (ADHD)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and post treatment (8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and post treatment (8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change Impairment Rating Scale (IRS) Parent Questionnaire Overall Severity Score
Change Impairment Rating Scale (IRS) Teacher Questionnaire Overall Severity Score
Change in Child Symptom Inventory-4 (CSI-4) Parent Checklist (Oppositional Defiant Disorder) ODD Symptom Severity Score
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: CLS-R-FUERTEExperimental Treatment1 Intervention
Active program participation in: a remote school clinician training and comprehensive psychosocial intervention designed to improve attention and behavior in Mexican school-aged youth (grades 1-5). via school clinician training by a clinical research team to lead parent skill groups, child skill groups, and teacher consultation in a behavioral classroom management system.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CLS-R-FUERTE
2022
N/A
~230

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,789 Previous Clinical Trials
2,690,363 Total Patients Enrolled
11 Trials studying Oppositional Defiant Disorder
2,922 Patients Enrolled for Oppositional Defiant Disorder
University of California, San FranciscoLead Sponsor
2,510 Previous Clinical Trials
15,243,640 Total Patients Enrolled
1 Trials studying Oppositional Defiant Disorder
163 Patients Enrolled for Oppositional Defiant Disorder
Lauren M Haack, PhDPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
163 Total Patients Enrolled
1 Trials studying Oppositional Defiant Disorder
163 Patients Enrolled for Oppositional Defiant Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there availability for individuals to participate in this medical experiment?

"Indeed, the most recent information hosted on clinicaltrials.gov indicates that this trial is actively recruiting. The study first began being publicised on September 1st 2021 and was last updated June 15th 2022. 69 participants are needed to be recruited from a single medical site."

Answered by AI

What is the highest number of participants recruited for this research project?

"Yes, the information available on clinicaltrials.gov suggests that this experiment is still seeking candidates. The investigation was initially made public September 1st 2021 and has undergone edits as recently as June 15th 2022. A total of 69 individuals are being recruited from a single site."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
UCSF
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

~18 spots leftby May 2025